UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1201
Qualys
QLYS
$7.75B
| $10.4M | ﹤0.01% |
75,577
-341,010
| -82% | -$33.5M |
2013 Q2
52 quarters
|
|
1202
Toyota
TM
$231B
| $10.3M | ﹤0.01% |
61,258
| – | – |
2025 Q4
2 quarters
|
|
1203
Palvella Therapeutics
PVLA
$2.11B
| $10.3M | ﹤0.01% |
67,469
-2,432
| -3% | -$295K |
2025 Q4
2 quarters
|
|
1204
PTC Therapeutics
PTCT
$5.01B
| $10.3M | ﹤0.01% |
126,011
-952
| -0.7% | -$68.7K |
2014 Q3
47 quarters
|
|
1205
Ollie's Bargain Outlet
OLLI
$5.36B
| $10.3M | ﹤0.01% |
133,619
-13,733
| -9% | -$1.15M |
2015 Q3
43 quarters
|
|
1206
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.59B
| $10.2M | ﹤0.01% |
160,225
| – | – |
2026 Q1
1 quarter
|
|
1207
Adeia
ADEA
$2.36B
| $10.2M | ﹤0.01% |
310,445
+55,446
| +22% | +$1.64M |
2013 Q2
52 quarters
|
|
1208
Plains GP Holdings
PAGP
$5.62B
| $10.2M | ﹤0.01% |
418,496
-7,185
| -2% | -$172K |
2015 Q4
42 quarters
|
|
1209
Rigetti Computing
RGTI
$3.75B
| $10.1M | ﹤0.01% |
524,476
-31,618
| -6% | -$611K |
2025 Q1
5 quarters
|
|
1210
Fulton Financial
FULT
$4.48B
| $10.1M | ﹤0.01% |
416,955
+4,303
| +1% | +$94.3K |
2013 Q2
52 quarters
|
|
1211
AZZ Inc
AZZ
$4.02B
| $10.1M | ﹤0.01% |
64,953
-1,168
| -2% | -$166K |
2023 Q1
13 quarters
|
|
1212
Dimensional Global Core Plus Fixed Income ETF
DFGP
$3.74B
| $10.1M | ﹤0.01% |
184,792
| – | – |
2026 Q1
1 quarter
|
|
1213
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
| $10.1M | ﹤0.01% |
+200,000
| New | +$10M |
2026 Q2
0 quarters
|
|
1214
Covista Inc
CVSA
$4.13B
| $10.1M | ﹤0.01% |
80,655
+5,601
| +7% | +$675K |
2013 Q2
52 quarters
|
|
1215
Organon & Co
OGN
$3.63B
| $10M | ﹤0.01% |
742,009
-36,896
| -5% | -$441K |
2021 Q2
20 quarters
|
|
1216
Diversified Healthcare Trust
DHC
$1.88B
| $10M | ﹤0.01% |
1,078,410
-2,774
| -0.3% | -$22.7K |
2026 Q1
1 quarter
|
|
1217
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $10M | ﹤0.01% |
146,418
+124,978
| +583% | +$8.16M |
2025 Q4
2 quarters
|
|
1218
Cabot Corp
CBT
$3.84B
| $10M | ﹤0.01% |
110,259
+15,561
| +16% | +$1.27M |
2013 Q2
52 quarters
|
|
1219
Vishay Intertechnology
VSH
$4.1B
| $10M | ﹤0.01% |
185,058
-237,605
| -56% | -$9.7M |
2013 Q2
52 quarters
|
|
1220
Definium Therapeutics
DFTX
$4.88B
| $9.9M | ﹤0.01% |
211,183
+208,770
| +8,652% | +$5.16M |
2024 Q2
8 quarters
|
|
1221
Dolby
DLB
$5.81B
| $9.9M | ﹤0.01% |
188,926
+8,051
| +4% | +$462K |
2013 Q2
52 quarters
|
|
1222
Oruka Therapeutics
ORKA
$6.41B
| $9.9M | ﹤0.01% |
104,310
+87,408
| +517% | +$5.82M |
2025 Q4
2 quarters
|
|
1223
Duolingo
DUOL
$6.16B
| $9.9M | ﹤0.01% |
86,296
+1,834
| +2% | +$201K |
2021 Q4
18 quarters
|
|
1224
MDU Resources
MDU
$4.15B
| $9.9M | ﹤0.01% |
467,864
-6,837
| -1% | -$149K |
2013 Q2
52 quarters
|
|
1225
NorthWestern Energy
NWE
$4.91B
| $9.9M | ﹤0.01% |
138,393
+748
| +0.5% | +$53K |
2013 Q2
52 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.